used for plaque assays and for the determination of virus yields in liquid overlay (13) . The influenza viruses employed in this study included A/HK/8/68 (H3N2) virus (HK virus), A/PR/8/34 (HON1) virus (PR8 virus), A/NED/84/68 (H2N2) virus (NED virus) , and A/WSN/33 (HON1) virus (WSN virus) . Among the recombinant viruses employed in this study are several that have been described previously. These recombinants are summarized in Table 1 . Additional recombinants derived from HK and PR8 viruses (R4, R6, R8, and Rll) were isolated and characterized by methods which have been described previously (11, 13, 15) . Recombinants R13 through R21 were derived from backcrossing recombinants R9 and R12. Recombinants R22 and R23 were derived from a backcross of R12 and R10; and R24 was derived from a backcross of R15 and R19. The gene compositions of recombinants Rl through R24 are given in Tables 2 through   5 .
Plaque assays. Titrations were routinely conducted by using MDCK cell monolayers in accordance with previously described methods (19) . Infected monolayers were incubated for 30 min at 370C to allow virus adsorption before application of overlays containing different concentrations of amantadine. Comparisons of this assay system with titrations conducted by preincubating cell monolayers with amantadine for 1.5 h before infection indicated that preincubation of cells with amantadine did not alter 50% plaque reduction end points.
Chemicals. Amantadine hydrochloride (Symmetrel, 1-adamantanamine) and rimantadine hydrochloride were generously provided by C. E. Hoffmann Fig. 1 ). It should be noted that a few small turbid NED virus plaques were observed at amantadine concentrations which were completely inhibitory for HK virus (2.7 to 24.3 ,g/ml).
Relationship of hemagglutinin and neuraminidase to amantadine resistance in recombinants derived from HK virus and PR8 virus. The data shown in Fig. 1 indicated that HK and PR8 viruses were sufficiently different in their amantadine sensitivity to permit analysis of the amantadine resistance of genetically defined recombinants derived from these two viruses. Recombinant viruses in which only the hemagglutinin and/or viral neuraminidase genes were exchanged were first examined for sensitivity to amantadine ( Figure 2 demonstrates that HA yields obtained from PR8 virus-infected cells were not reduced in the presence of 25 ,ug of amantadine per ml. In contrast, a significant delay in the appearance of peak HA titers was observed with HK virus in the presence of the same concentration of amantadine. The virus yields obtained from two representative recombinants were also examined. R11, which was found to be resistant to amantadine when examined by the plaque reduction assay, was also found to be resistant in this system. Similarly, Rl, which had previously been determined to be sensitive, followed the same kinetics of growth that were observed with the HK virus parent. When R12, an amantadine-resistant recombinant possessing an HK virus M protein, was examined by the same procedures, it was again found to be much more resistant to amantadine inhibition than the HK virus parent (data not shown). It should be noted that, although the onset of HA production of amantadine-sensitive viruses is delayed, amantadine-treated and control monolayers eventually yield nearly equivalent HA titers.
Amantadine sensitivity of recombinants derived from WSN and NED viruses and WSN and HK viruses. To confirn the relationship between amantadine sensitivity and the gene coding for M protein, we employed the plaque assay system to determine the amantadine sensitivity of other genetically defined viruses. Table 5 summarizes the results obtained with three recombinants derived from amantadine-resistant WSN virus and amantadine-sensitive NED virus. RVII-4, which derives only the genes coding for P1 and M proteins from NED virus, was found to be amantadine sensitive. Analysis of two amantadine-resistant recombinants, RV-5 and RV-6, also suggests that amantadine susceptibility is determined by the gene coding for M protein. Both of these amantadine-resistant recombinants derive the gene coding for M protein from the amantadine-resistant parent (WSN virus) .
Similarly, analysis of recombinants derived from WSN and HK viruses ( Mutation of HK virus to amantadine resistance. Next, a study was undertaken to examine the frequency of emergence of amantadine-resistant HK virus variants. Two amantadine-sensitive HK virus clones were initially obtained by plaque isolation and then passaged in embryonated eggs. MDCK cells were then infected with 5 x 103 PFU/dish with each of these cloned viruses, and an agar overlay medium containing 10 ,ug of amantadine per ml was added. Normal-sized plaques were selected and plaqued again in the presence of 10 ,ug of amantadine per ml. These isolates were found to be about 100 times as resistant to amantadine as the HK virus parent. Furthermore, after four passages in embryonated eggs in the absence of amantadine, these viruses were again found to be highly resistant to amantadine. Based on the ratio of normal-sized plaques in the presence and absence of amantadine, a crude estimate was obtained for the frequency of emergence of amantadine-resistant mutants, indicating that there were four amantadine-resistant variants per 10,000 PFU. These results are slightly lower than those obtained by Appleyard, who observed the emergence of approximately 0.1% amantadine-resistant mutants in a population of amantadine-sensitive influenza A/Bel/42 virus (2) . DISCUSSION The analysis of 24 recombinants derived from HK and PR8 viruses indicated that differences in susceptibility to amantadine are most closely associated with differences in the gene coding for M protein.
Our results indicate that all recombinants deriving an M gene from PR8 virus are resistant to amantadine. Of particular interest is Rll, an amantadine-resistant recombinant deriving only the M gene from PR8 virus. Comparison of the gene compositions of R8 and R7 demonstrates that these recombinants are identical with respect to the derivation of all genes with the exception of the gene coding for M protein. R8, which derives the M gene from PR8 virus, was found to be resistant, and R7, which derives the M gene from HK virus, was found to be sensitive. Identical results are obtained from comparisons of four other pairs of recombinants: Rl and R9, R3 and R24, R4 and R15, and R13 and R21 (Tables 2, 3 , and 4).
Although all amantadine-sensitive recombinants were found to contain an HK virus M gene, two amantadine-resistant recombinants (R12 and R19; Tables 3 and 4) were isolated which also derived the M gene from HK virus. R19 derived all other genes from PR8 virus, and R12 derived all other genes from PR8 virus with the exception of the HA gene. These results indicate that in the presence of a preponderance of other genes derived from the resistant parent, amantadine sensitivity in recombinants containing an HK virus M gene may not be expressed.
Comparison of the recombinants R19 and R24, both of which derive the M gene from HK virus and which are identical with respect to all other genes except the NA gene ( Table 4 ), indicates that under these conditions the HK virus neuraminidase may influence the expression of amantadine sensitivity. Comparison of other paired viruses, such as R15 and R19, similarly suggests that under certain conditions the HK virus neuraminidase may influence the expression of amantadine sensitivity. On the other hand, comparison of recombinants R12 and R19 suggests that, under similar conditions, the HK virus hemagglutinin most likely does not influence amantadine sensitivity in recombinants with an HK virus M gene. Comparison of R19 and R22, recombinants which are identical with respect to all genes except the P1 gene, indicates that in combination with an HK virus M gene, the P1 gene also influences amantadine sensitivity. It shoud be noted that R22 appears to be significantly less sensitive to amantadine than does HK virus, indicating that susceptibility to amantadine is not always transferred as an allor-none character. As recombinants representing all possible gene combinations are not available, it is at present not possible to identify each gene or gene combination which may influence the amantadine sensitivity of recombinants containing an HK virus M gene. However, it should be emphasized that, whatever influences other genes or combinations of genes exert, the presence of an M gene from a sensitive parent is required for amantadine sensitivity to be expressed.
The analysis of recombinants derived from crosses of WSN virus and HK or NED viruses provides additional data linking the M gene and susceptibility to amantadine. A direct association of amantadine susceptibility and the gene coding for M protein was observed in the analysis of these recombinants.
Our results suggest that amantadine resistance in R12 and R19, two recombinants containing an M protein from HK virus, is not due to mutation. However, it appears that the frequency of mutation to amantadine resistance is surprisingly high. Our data and those of Appleyard (2) suggest that amantadine-resistant mutants are found at a frequency of about 0.04 to 0.1%.
The mechanism by which amantadine inhibits influenza virus replication has not been fully elucidated. However, there is considerable evidence (5) (6) (7) (8) 18 ) that amantadine inhibits an early event in the virus replication cycle, either by preventing virus penetration (5) or virus uncoating (7) or by blocking primary transcription (6) . From the present results, the possibility cannot be excluded that amantadine acts by inhibiting primary transcription and that differences in M protein determine the rate at which amantadine reaches its possible target in the ribonucleoprotein complex. It would appear more likely, however, that amantadine inhibits either virus penetration or virus uncoating and that differences in the M protein directly determine the extent to which amantadine inhibits this event.
Previously, it has been shown that the capacity of recombinants for high yield in eggs requires the presence of the genes coding for M and NP proteins from high-yielding parents (17a). Thus, the relationship of strain-associated differences in amantadine susceptibility to M protein represents an additional example of differences in biological properties associated with differences in M proteins.
